Skip to main content
Caplight Logo









STENTiT

STENTiT

Private
EindhovenHealthcare & Life Scienceshttps://www.stentit.com/

Last Round

Series A

Jun 25, 2025

Total Funding Raised

$4.67M

Company Overview

STENTiT is a medical device company developing regenerative endovascular implants that trigger a natural healing response to restore arteries from the inside-out.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bioresorbable stentregenerative medicinevascular surgeryperipheral artery diseasePADchronic limb-threatening ischemiaCLTIresorbable scaffoldendovascular implantbio-scaffoldinterventional cardiologyvascular reconstructionmedtechbiomaterialsdissolvable stent

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

STENTiT Comparables

Compare STENTiT with similar companies based on industry and business-model similarity.

STENTiT comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
R3 Vascular Inc.
86%
Zorion Medical
85%
REVA Medical
83%

STENTiT Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 25, 2025
GrantJul 4, 2023
SeedApr 25, 2022

Key People

Founding team and executive leadership

Bart Sanders

CEO & Co-Founder

Founding Team

STENTiT Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 209% MoM, reaching 1.5K.

  • Jun 25, 2025

    $35M round led by European Innovation Council

STENTiT Filings

Explore SEC and related filing metadata, where available.

STENTiT filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about STENTiT's valuation, stock price, and market status.

Is STENTiT a public or private company?

STENTiT is a private company.

What is the current stock price of STENTiT?

STENTiT is a private company with no public stock price. No recent secondary market data is available.

How much is STENTiT worth (valuation)?

Valuation information for STENTiT is not publicly available.

Can I buy STENTiT stock?

STENTiT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was STENTiT's last funding round?

STENTiT's most recent funding round was Grant on June 23, 2023.

Who are the main investors in STENTiT?

Key investors in STENTiT include European Innovation Council, Brabantse Ontwikkelings Maatschappij, Nextgen Ventures.

Will STENTiT IPO soon?

No public IPO plans have been announced for STENTiT.

How can I track STENTiT secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor STENTiT's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEindhoven
Employee Range14
Year Founded2017
Last FundingJun 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?